The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years
- PMID: 19372179
- DOI: 10.1093/jac/dkp074
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years
Abstract
The importance of neutropenia as a predisposing factor for infection in patients with haematological malignancies was not clearly appreciated until effective therapeutic agents became available. This led to the important advance of administering antibiotics promptly to neutropenic patients when they developed fever, before a diagnosis was established. Although some antibiotics available in the 1960s had activity against many pathogens in vitro, they were ineffective against infections in neutropenic patients. The development of methods to administer white blood cell transfusions along with antibiotics was beneficial to some patients. The development of new antibiotics was of critical importance, such as methicillin for treatment of Staphylococcus aureus and carbenicillin for Pseudomonas aeruginosa. Prevention of infection was attempted, using isolation rooms, air filtration and prophylactic antibiotics. All of these early efforts laid the foundations for the many important current investigations.
Similar articles
-
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why monotherapy?J Antimicrob Chemother. 2009 May;63 Suppl 1:i18-20. doi: 10.1093/jac/dkp077. J Antimicrob Chemother. 2009. PMID: 19372175 Review.
-
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Where do we go from here?J Antimicrob Chemother. 2009 May;63 Suppl 1:i16-7. doi: 10.1093/jac/dkp076. J Antimicrob Chemother. 2009. PMID: 19372174 Review.
-
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?J Antimicrob Chemother. 2009 May;63 Suppl 1:i14-5. doi: 10.1093/jac/dkp075. J Antimicrob Chemother. 2009. PMID: 19372173 Review.
-
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Summary and comments.J Antimicrob Chemother. 2009 May;63 Suppl 1:i41-3. doi: 10.1093/jac/dkp082. J Antimicrob Chemother. 2009. PMID: 19372182 Review. No abstract available.
-
Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.Int J Antimicrob Agents. 2005 Dec;26 Suppl 2:S123-7; discussion S133-40. doi: 10.1016/j.ijantimicag.2005.08.001. Epub 2005 Oct 24. Int J Antimicrob Agents. 2005. PMID: 16249072
Cited by
-
Overall equipment effectiveness, efficiency and slide review analysis of high-end hematology analyzers.Pract Lab Med. 2022 Apr 18;30:e00275. doi: 10.1016/j.plabm.2022.e00275. eCollection 2022 May. Pract Lab Med. 2022. PMID: 35601458 Free PMC article.
-
The Microbiome and Its Impact on Allogeneic Hematopoietic Cell Transplantation.Cancer J. 2023 Mar-Apr 01;29(2):75-83. doi: 10.1097/PPO.0000000000000645. Cancer J. 2023. PMID: 36957977 Free PMC article.
-
The Impact of Dimitrios P. Kontoyiannis on Mucormycosis Research.J Fungi (Basel). 2024 May 27;10(6):382. doi: 10.3390/jof10060382. J Fungi (Basel). 2024. PMID: 38921367 Free PMC article.
-
Immunization of children receiving immunosuppressive therapy for cancer or hematopoietic stem cell transplantation.Ochsner J. 2012 Fall;12(3):228-43. Ochsner J. 2012. PMID: 23049460 Free PMC article.
-
Development and Applications of Prognostic Risk Models in the Management of Invasive Mold Disease.J Fungi (Basel). 2018 Dec 19;4(4):141. doi: 10.3390/jof4040141. J Fungi (Basel). 2018. PMID: 30572637 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
